Printed From BioPortfolio.com

New Biotech Startup to Use $19M in Funding to Advance Dual Cancer Therapies

16:00 EDT 16 Oct 2017 | Drug Discovery Development

News

More recent research suggests that inhibition of STAT proteins has also a profound impact on the tumor microenvironment.

Contributed Author:

Janpix

Topics:

Original Article: New Biotech Startup to Use $19M in Funding to Advance Dual Cancer Therapies

Drug Discovery Development

More From BioPortfolio on "New Biotech Startup to Use $19M in Funding to Advance Dual Cancer Therapies"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Advertisement

News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

BioPortfolio Limited

Social Media

Publish Content

Agreements

Tools

Help

This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2017 BioPortfolio Limited. Site developed by Alacrify Ltd.